OLAGACT Trademark

Trademark Overview

On Friday, July 21, 2017, a trademark application was filed for OLAGACT with the United States Patent and Trademark Office. The USPTO has given the OLAGACT trademark a serial number of 87537797. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 2, 2021. This trademark is owned by Bristol-Myers Squibb Company. The OLAGACT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
olagact

General Information

Serial Number87537797
Word MarkOLAGACT
Filing DateFriday, July 21, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 2, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, August 2, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 2, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 12, 2021EXTENSION 5 GRANTED
Monday, December 28, 2020EXTENSION 5 FILED
Tuesday, January 12, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 28, 2020TEAS EXTENSION RECEIVED
Tuesday, June 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 26, 2020EXTENSION 4 GRANTED
Friday, June 26, 2020EXTENSION 4 FILED
Friday, June 26, 2020TEAS EXTENSION RECEIVED
Wednesday, December 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 23, 2019EXTENSION 3 GRANTED
Monday, December 23, 2019EXTENSION 3 FILED
Monday, December 23, 2019TEAS EXTENSION RECEIVED
Friday, June 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2019EXTENSION 2 GRANTED
Wednesday, June 19, 2019EXTENSION 2 FILED
Wednesday, June 19, 2019TEAS EXTENSION RECEIVED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 19, 2018EXTENSION 1 GRANTED
Wednesday, December 19, 2018EXTENSION 1 FILED
Wednesday, December 19, 2018TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 26, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 1, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 1, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 21, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 21, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 27, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, September 27, 2017PRIORITY ACTION E-MAILED
Wednesday, September 27, 2017PRIORITY ACTION WRITTEN
Tuesday, September 26, 2017ASSIGNED TO EXAMINER
Thursday, July 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 25, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

olagact diseases pharmaceutical human anti preparations disorders organ solid auto immune